InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Coiante Scott M, 首席财务官. Insider active across 3 companies, notably Aprea Therapeutics, Inc.. In total, 8 filings have been published. History available since 25 August 2021. The latest transaction was disclosed on 26 August 2024 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Coiante Scott M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
160,237 股Common StockSEC:0001062822-26-000035:0
15,000 股@ US$1.52100.0% 占其流量Common StockSEC:0001104659-24-092946:0
20,000 股0Common StockSEC:0001104659-23-106855:0
60,800 股0Common StockSEC:0001104659-22-084760:0
35,284 股@ US$0.80535.3% 占其流量Common StockSEC:0001104659-22-069009:0
42,900 股0Common StockSEC:0001104659-22-033391:0
14,817 股@ US$1.7430.7% 占其流量Common StockSEC:0001104659-22-028760:0
7,534 股@ US$3.9834.0% 占其流量Common StockSEC:0001104659-21-110596:0
8 条申报中的 8 条
About Coiante Scott M
Coiante Scott M is Chief Financial Officer. The record lists 8 filings in total. Across the 8 most recent filings available, the transactions run from 2021-08-27 to 2026-03-03, with 0 in buys and 20422 in sells, and the most frequent transaction nature is Attribution. The companies mentioned are Aprea Therapeutics, Inc., Agile Therapeutics INC, and Lexicon Pharmaceuticals, INC.
